US agency develops toolkit for obtaining informed consent
This article was originally published in SRA
The US Agency for Healthcare Research and Quality has developed a “toolkit” to facilitate the process of obtaining informed consent from potential research subjects1. It also provides recommendations on obtaining authorisation for the use of subjects’ protected health information.
You may also be interested in...
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.